What they were paid
FATE THERAPEUTICS Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,875 | $0 | $58,086 | $0 | $118,961 |
| FY2024 | $58,000 | — | $114,923 | $0 | $172,923 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: FATE THERAPEUTICS INC DEF 14A filed April 24, 2026, accession 0001193125-26-177094, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025FATE THERAPEUTICS pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation (Chair) · Science & Technology
The rest of the FATE THERAPEUTICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Bahram Valamehr | Director | $0 |
| Laura J. Hamill | Director | $0 |
| Matthew C. Abernethy | Independent Director | $151,612 |
| Michael Lee | Independent Director | $104,086 |
| Robert S. Epstein | Independent Director | $123,711 |
| Shefali Agarwal | Independent Director | $115,086 |
| William H. Rastetter | Chair of the Board | — |
| Yuan Xu | Independent Director | $111,524 |
The full FATE THERAPEUTICS compensation record
free company briefThis page is one director within FATE THERAPEUTICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat